SCHEMBL11826895

SCHEMBL11826895

O=C(O)c1cc(SCc2cccc(Cl)c2)cc(S(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPRC P08575 1/20 0.46
▸ PTPRG P23470 1/20 0.46
▸ AR P10275 1/20 0.45
▸ MRGPRX4 Q96LA9 1/20 0.45
▸ PLA2G1B P04054 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ ATG4B Q9Y4P1 1/20 0.45
▸ AKR1C3 P42330 1/20 0.44
▸ TAS2R14 Q9NYV8 2/20 0.42
▸ DAO P14920 2/20 0.41
▸ LMNA P02545 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39
▸ RXRG P48443 1/20 0.39
▸ NR4A2 P43354 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11823334 0.88 MCL1 (0.44) PTPRCPLA2G1BMAPTATG4BAKR1C3
SCHEMBL11821945 0.87 DAO (0.47) MRGPRX4PLA2G1BMAPTATG4BDAO
SCHEMBL11822234 0.79 L3MBTL1 (0.57) ARMRGPRX4MAPTLMNAL3MBTL1
SCHEMBL11818815 0.78 MRGPRX4 (0.42) MRGPRX4PLA2G1BMAPTATG4BNR4A2
SCHEMBL11820185 0.77 AKR1C3 (0.43) AKR1C3TAS2R14LMNAL3MBTL1POLB
SCHEMBL11818315 0.77 AKR1C3 (0.54) PTPRCPTPRGARMRGPRX4MAPT
SCHEMBL11810807 0.77 ALDH1A1 (0.41) MAPTLMNAPOLBMEN1KMT2A
SCHEMBL13802466 0.77 MRGPRX4 (0.63) PTPRCPTPRGARMRGPRX4PLA2G1B
SCHEMBL693069 0.75 RXRA (0.57) PTPRCPTPRGARMRGPRX4MAPT
SCHEMBL11825039 0.72 DAO (0.53) MRGPRX4PLA2G1BMAPTATG4BDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 — — US disclosed
Send feedback